Finally, activation of AhR and β-catenin modulated the expression of downstream cell proliferation- and EMT-related molecules to promote proliferation and metastasis of IDO1-overexpressing HCC cells. The gene discussed is IDO1; the disease is hepatocellular carcinoma.